PULMONARY NODULAR LYMPHOID HYPERPLASIA

PULMONARY NODULAR LYMPHOID HYPERPLASIA was reported 11 times

PULMONARY NODULAR LYMPHOID HYPERPLASIA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Non-narcotic Antitussive [EPC] 1 0.0001
1 Programmed Death Receptor-1 Blocking Antibody [EPC] 1 0.0000
2 Platinum-based Drug [EPC] 2 0.0000
3 Azole Antifungal [EPC] 1 0.0000
4 CD20-directed Cytolytic Antibody [EPC] 2 0.0000
5 Expectorant [EPC] 1 0.0000
6 Angiotensin 2 Receptor Blocker [EPC] 1 0.0000
7 Corticosteroid [EPC] 4 0.0000
8 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
9 Loop Diuretic [EPC] 1 0.0000
10 Tumor Necrosis Factor Blocker [EPC] 1 0.0000